Sumatriptan Tablet
Product Images NDC 68788-6769

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68788-6769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
Estimated probability of remediation or rescue is presented in the text. There also seems to be a table consisting of various dosages. Additionally, the text includes a mention of the time in hours from bilial bese, which is not clear and could be an error.*
FDA Label Image

Sumatriptan Succinate Tablets, Usp 25mg (Sumatriptan Fig3)

Sumatriptan Succinate Tablets, Usp 25mg (Sumatriptan Fig3)
This is a description of Sumatriptan Succinate Tablets, USP 25mg, which is the generic version of Imitrex. The tablets are manufactured by Aurobindo Pharma Limited and each tablet contains Sumatriptan succinate equivalent to 25mg of sumatriptan. The directions in English suggest taking the tablet(s) every few hours with caution suggested against transferring the drug to anyone other than the patient for whom it was prescribed. The text also includes some illegible characters and hence some of the details are not available.*
FDA Label Image

Chemical Structure (Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.